Registre des publications 

Tous les résultats des travaux de recherche de l'IFCT, même négatifs, ont vocation à etre publiés dans des journaux médicaux de premier plan. Ces résultats font aussi l’objet de présentations orales et posters lors des congrès scientifiques de référence. Parmi ces congrès figurent notamment ceux de l'ASCO, ESMO et du WCLC.

 

13 résultats

Pathomics-based prediction of thymic epithelial tumor subtypes within the French RYTHMIC network.

Auteurs / Authors
L. Zullo
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT

Pathomics-based prediction of thymic epithelial tumor subtypes within the French RYTHMIC network

Auteurs / Authors
Lodovica Zullo, Mathilde Bateson, Jose Benitez-Montanez, Audrey Mansuet-Lupo, Damien Sizaret, Juan Florez-Arango, Alvaro Lopez-Gutierrez, Daniela Miliziano, Pascale Missy, Vincent De Montpreville, Olaf Mercier, Jordi Remon Masip, David Planchard, Nicolas Girard, Thierry Molina, Benjamin Besse
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT

Molecular profiling and survival in oncogene-addicted resected stage IIIAN2 non-small cell lung cancer (NSCLC): A study from the Lung ART IFCT 0503 trial

Auteurs / Authors
Victor Albarran-Artahona, Benjamin Besse, Ludovic Lacroix, Wael Zrafi, Diego Díaz-Jiménez, Maria Rosa Ghigna, Guillaume Granier, Nathalie Cozic, Emilie Bouvier-Morel, Julien Adam, Cecile Le Pechoux, Antonin Levy
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT

An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay

Auteurs / Authors
David Spigel, Virginie Westeel, Ian Anderson, Laurent Greillier, Florian Guisier, Olivier Bylicki, Firas Badin, Gaelle Rousseau-Bussac, Clotilde Deldycke, Frank Griesinger, Adam Bograd, Wangjian Zhong, Matthew Gubens, John Crowley, Heiko von der Leyen, Gavitt Woodard, Johannes Kratz, David Jablons, Michael Mann
Journal / Conference
ASCO
Année / Year
2025
PMID / session
Etude IFCT

Real World Data of everolimus in patients with Thymic epithelial tumors (TETs)

Auteurs / Authors
Á. López Gutié rrez , J.D. Florez Arango , J.C. Benitez Montanez , D. Miliziano , E. Dansin , G. Giaccone , C. Basse , J. Mazieres , T. Pierret , E. Pons-Tostivint , J. Arrondeau, M. Aldea , D. Diaz Jimé nez , L. Zullo, F. Aboubakar, P. Missy, J. Remon Masip, T. Molina, N. Girard, B. Besse
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT

Real World Data of lenvatinib in patients with Thymic epithelial tumors (TETs)

Auteurs / Authors
Á. López Gutiérrez , J.C. Benitez Montanez , J.D. Florez Arango , D. Miliziano , E. Dansin , G. Giaccone , C. Basse , J. Mazieres ,T. Pierret , E. Pons-Tostivint , J. Arrondeau, M. Aldea, D. Diaz Jiménez , L. Zullo, F. Aboubakar, P. Missy, J. Remon Masip, T. Molina, N. Girard, B. Besse
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT

Predictors of long-term response and survival in patients with extensive stage small cell lung cancer (ES-SCLC) receiving atezolizumab plus chemotherapy in a real-world setting (IFCT-1905 CLINATEZO)

Auteurs / Authors
L. Falchero , K. Amrane , B. Godbert , B. Leterre , J. Madelaine ,P. Fournel , C. Mascaux , J. Raimbourg , S. Schneider , A. Swalduz, R. Veillon, A. Langlais, P. Missy, F. Morin, V. Westeel, N. Girard
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT

Stratification of pleural mesothelioma patients for combined immunotherapy based on sarcomatoid component and tumour microenvironment markers in the IFCT-MAPS2 study

Auteurs / Authors
G. Tosato, Y. Blum, J-B. Assié, R. Sequeiros , A. Langlais , M. Arnould , F. Damiola , E. Amour, C. Meiller , M-C. Jaurand ,A. de Reynies , V. Westeel , J. Mazieres , L. Greillier , F. Morin ,S. Lantuejoul , A. Scherpereel, G. Zalcman, D. Jean
Journal / Conference
ELCC
Année / Year
2025
PMID / session
Etude IFCT

Sites of relapse and subsequent therapy in the BR.31 phase 3 study of durvalumab vs placebo in resected stage IB-IIIA NSCLC

Auteurs / Authors
V. Westeel , G. Goss , G. Darling , K. Nakagawa , B. Massuti Sureda , F. Perrone , S-A. McLachlan , J.H. Kang , Y-L. Wu ,A-M.C. Dingemans, R. Dziadziuszko, M. Okada, L. Greillier, C. Audigier-Valette, F. Morin, S. Sugawara, E. Nadal, M.R. Stockler, K. Ding, C. O’Callaghan
Journal / Conference
ELCC
Année / Year
2025
Etude IFCT

Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study

Auteurs / Authors
Wislez M, Mascaux C, Cadranel J, Thomas QD, Ricordel C, Swalduz A, Pichon E, Veillon R, Gounant V, Rousseau-Bussac G, Madroszyk A, Daniel C, Ravoire M, Metivier AC, Fournel P, Missy P, Morin F, Guisier F, Westeel V.
Journal / Conference
European Journal of Cancer
Année / Year
2025
PMID / session
Etude IFCT

Prognostic Value of FDG PET Metabolic Parameters Before and After 42 Gy of Radiochemotherapy in Patients with Inoperable Stage III Nonsmall Cell Lung Cancer

Auteurs / Authors
Vera P, Giraud P, Hapdey S, Gouel P, Jan O, Le Roux P, Langlais A, Lévêque E, Le Tinier F, Olivier A, Martin E, Berriolo-Riedinger A, Pourel N, Broglia JM, Boisselier P, Guillemard S, Salem N, Brenot-Rossi I, Garcia C, Berthold C, Giroux-Leprieur E, Moreau D, Guillerm S, Benali K, Tessonnier L, Audigier-Valette C, Lerouge D, Quak E, Massabeau C, Courbon F, Loo M, Larrouy A, Ghazzar N, Chaumet-Riffaud P, Amour E, Zalcman G, Modzelewski R, Thureau S.
Journal / Conference
Journal of Nuclear Medicine
Année / Year
2025
PMID / session
Etude IFCT